| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
129 |
90 |
$109K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,867 |
1,408 |
$96K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,581 |
1,347 |
$67K |
| 92134 |
|
3,390 |
2,667 |
$61K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,066 |
765 |
$43K |
| 92235 |
|
119 |
107 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
73 |
49 |
$6K |
| 67228 |
|
14 |
12 |
$4K |
| 92250 |
|
120 |
107 |
$3K |
| J3590 |
Unclassified biologics |
59 |
27 |
$525.00 |
| 4040F |
|
1,383 |
1,011 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
1,173 |
890 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,516 |
1,887 |
$0.00 |
| 2022F |
|
1,363 |
985 |
$0.00 |
| 1036F |
|
2,460 |
1,806 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
1,221 |
888 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,159 |
1,625 |
$0.00 |
| 4177F |
|
64 |
42 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
21 |
12 |
$0.00 |